Table 1.
AB resistance phenotype of the potentially pathogenic carbapenem resistant bacteria isolated from the discharged effluent samples.
| Bacteria | AMP10 | CTX5 | IPM10 | MEM10 | CIP5 | C30 | CN10 | TE30 | W5 | SXT25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Acinetobacter baumannii | R | R | R | R | R | R | R | R | R | S |
| Acinetobacter pittii | R | R | I | I | R | R | R | R | R | S |
| Acinetobacter oleivorans | R | R | I | I | R | R | S | R | R | R |
| Aeromonas caviae | * | * | * | * | S | * | * | * | * | R |
| Aeromonas veronii (1) | * | * | * | * | R | * | * | * | * | R |
| Aeromonas veronii (2) | * | * | * | * | R | * | * | * | * | S |
| Citrobacter portucalensis | R | R | R | R | R | R | R | R | R | R |
| Citrobacter sp. Y3 | R | R | R | R | R | R | R | R | S | S |
| Escherichia coli | R | R | R | R | R | S | R | R | R | R |
| Klebsiella pneumoniae | R | R | R | R | R | S | R | R | R | R |
AMP10—Ampicillin 10 µg; CTX5—Cefotaxime 5 µg; IMP10—Imipenem 10 µg; MEM10—Meropenem 10 µg; C30—Chloramphenicol 30 µg; CIP5—Ciprofloxacin 5 µg; CN10—Gentamicin 10 µg; TE30—Tetracycline 30 µg; W5—Trimethoprim 5 µg; SXT25—Trimethoprim + sulphamethoxazole 25 µg. * No EUCAST breakpoints available; S—Susceptible, standard dosing regimen; I—Susceptible, increased exposure; R—Resistant.